Citation Impact
Citing Papers
Cross‐presentation of epitopes on virus‐like particles via the MHC I receptor recycling pathway
2011
Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma
2011
Targeted inactivation of CTNNB1 reveals unexpected effects of β-catenin mutation
2002
Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers
2018 StandoutNobel
Vaccination with Antigen-Transfected, NKT Cell Ligand–Loaded, Human Cells Elicits Robust In Situ Immune Responses by Dendritic Cells
2012
LncRNA HOXA11-AS Promotes Proliferation and Invasion of Gastric Cancer by Scaffolding the Chromatin Modification Factors PRC2, LSD1, and DNMT1
2016 Standout
Genome-wide identification and functional analysis of Apobec-1-mediated C-to-U RNA editing in mouse small intestine and liver
2014
CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes
2016
Vitiligo-Like Depigmentation in Patients With Stage III-IV Melanoma Receiving Immunotherapy and Its Association With Survival: A Systematic Review and Meta-Analysis
2015
Enhancing the immunogenicity of tumour lysate-loaded dendritic cell vaccines by conjugation to virus-like particles
2011
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
Why do cancers have high aerobic glycolysis?
2004 Standout
Osteosarcoma incidence and survival rates from 1973 to 2004
2009 Standout
Automated electron microscope tomography using robust prediction of specimen movements
2005 Standout
Methods for selection of aptamers to protein targets
2007
Therapeutic cancer vaccines: are we there yet?
2010
In vitro selection of ribozymes dependent on peptides for activity
2003
Trial watch
2012
Innate and adaptive immune cells in the tumor microenvironment
2013 Standout
Dendritic cell vaccination in human melanoma: relationships between clinical effects and vaccine parameters
2010
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Molecular monitoring of BCR–ABL as a guide to clinical management in chronic myeloid leukaemia
2005
Bioimmunoadjuvants for the treatment of neoplastic and infectious disease: Coley's legacy revisited
2009
Mutated KRAS results in overexpression of DUSP4, a MAP‐kinase phosphatase, and SMYD3, a histone methyltransferase, in rectal carcinomas
2010
Aptamers and aptamer targeted delivery
2009
Cancer immunotherapy via dendritic cells
2012 Standout
Structure of Dengue Virus
2002 Standout
Trial watch
2013
Cancer stem cells revisited
2017 Standout
HSP90 and the chaperoning of cancer
2005 Standout
Tumor-Associated Macrophages: From Mechanisms to Therapy
2014 Standout
EGF–ERBB signalling: towards the systems level
2006 Standout
Delivery technologies for cancer immunotherapy
2019 Standout
Antibody therapy of cancer
2012 Standout
The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments
2017
Aptamers as therapeutics
2010 Standout
Targeting cancer with small molecule kinase inhibitors
2008 Standout
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
2009 Standout
Aptamers as targeted therapeutics: current potential and challenges
2016 Standout
Emerging targets in cancer immunotherapy
2017
Production of immune-modulatory nonclassical molecules HLA-G and HLA-E by tumor infiltrating ameboid microglia/macrophages in glioblastomas: A role in innate immunity?
2010
Targeting Epidermal Growth Factor Receptor in Head and Neck Cancer
2022
Interferons and viruses: an evolutionary arms race of molecular interactions
2015 StandoutNobel
Transcriptional Regulation of Adrenocortical Steroidogenic Gene Expression
2007
DNA Aptamers That Bind to MUC1 Tumour Marker: Design and Characterization of MUC1-Binding Single-Stranded DNA Aptamers
2006
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Fusobacterium nucleatum Promotes Colorectal Carcinogenesis by Modulating E-Cadherin/β-Catenin Signaling via its FadA Adhesin
2013 Standout
Cytokines in Cancer Immunotherapy
2017
Osteosarcoma: Basic Science and Clinical Implications
2006
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
New views of cells in 3D: an introduction to electron tomography
2004
Cancer as an evolutionary and ecological process
2006 Standout
Allogeneic tumor cell vaccines
2013
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Novel electrochemical sensor system for protein using the aptamers in sandwich manner
2004
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
2017 Standout
An evolutionary model of carcinogenesis.
2003
Functional Nucleic Acid Sensors
2009 Standout
Differentiation therapy of leukemia: 3 decades of development
2009
CD81 Is Required for Hepatitis C Virus Glycoprotein-Mediated Viral Infection
2004 StandoutNobel
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Human Parvovirus B19
2002 Standout
Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients
1996 StandoutNobel
Diverse Hepatitis C Virus Glycoproteins Mediate Viral Infection in a CD81-Dependent Manner
2004 StandoutNobel
CTLA-4+ Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate with Poor Prognosis
2015
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
2018 Standout
Tumor Antigen–Targeted, Monoclonal Antibody–Based Immunotherapy: Clinical Response, Cellular Immunity, and Immunoescape
2010
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
2011 Standout
CD8+tumor-infiltrating lymphocytes at primary sites as a possible prognostic factor of cutaneous angiosarcoma
2013 StandoutNobel
The ins and outs of APC and β‐catenin nuclear transport
2002
Growth of Pseudotypes of Vesicular Stomatitis Virus with N-Tropic Murine Leukemia Virus Coats in Cells Resistant to N-Tropic Viruses
1973 StandoutNobel
Electrochemical Detection of Protein Using a Double Aptamer Sandwich
2004
Ribonucleic Acud Polymerase in Virions of Newcastle Disease Virus: Comparison with the Vesicular Stomatitis Virus Polymerase
1971 StandoutNobel
Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR
2003 StandoutNobel
Design of a hyperstable 60-subunit protein icosahedron
2016 StandoutNatureNobel
The Tumor Microenvironment Innately Modulates Cancer Progression
2019 Standout
Alanine Scanning of the Hepatitis C Virus Core Protein Reveals Numerous Residues Essential for Production of Infectious Virus
2007 StandoutNobel
Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses
2006 StandoutNobel
Regulatory T cells expressing abundant CTLA‐4 on the cell surface with a proliferative gene profile are key features of human head and neck cancer
2018 StandoutNobel
Low-Dose Adenovirus Vaccine Encoding Chimeric Hepatitis B Virus Surface Antigen-Human Papillomavirus Type 16 E7 Proteins Induces Enhanced E7-Specific Antibody and Cytotoxic T-Cell Responses
2005 StandoutNobel
Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.
1992 Standout
Aptameric Enzyme Subunit for Biosensing Based on Enzymatic Activity Measurement
2006
Functional requirements of AID’s higher order structures and their interaction with RNA-binding proteins
2016 StandoutNobel
Immunotherapy of cancer: from monoclonal to oligoclonal cocktails of anti‐cancer antibodies: IUPHAR Review 18
2016
Works of Michele Bianchini being referenced
A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predictor of disease progression
2008
IL-15 and IL-2 increase Cetuximab-mediated cellular cytotoxicity against triple negative breast cancer cell lines expressing EGFR
2011
APC Senses Cell–Cell Contacts and Moves to the Nucleus upon Their Disruption
2001
Identification of candidate genes involved in the reversal of malignant phenotype of osteosarcoma cells transfected with the liver/bone/kidney alkaline phosphatase gene
2004
Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8+ T lymphocytes
2007
IL-2- or IL-15-activated NK cells enhance Cetuximab-mediated activity against triple-negative breast cancer in xenografts and in breast cancer patients
2012
Specific oligobodies against ERK-2 that recognize both the native and the denatured state of the protein
2001
Complete remission in acute myeloid leukemia with granulocyte-colony stimulating factor without chemotherapy. Report of cytogenetic remission of a t(9;11)(p22q23) positive AML patient and review of literature.
2003
Identification and Developmental Changes of Aromatase and Estrogen Receptor Expression in Prepubertal and Pubertal Human Adrenal Tissues
2007
Denaturing-HPLC-Based Assay for Detection of ABL Mutations in Chronic Myeloid Leukemia Patients Resistant to Imatinib
2004
Human leukocyte antigen-E protein is overexpressed in primary human colorectal cancer
2008
Comparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosa
2006
Cetuximab-mediated cellular cytotoxicity is inhibited by HLA-E membrane expression in colon cancer cells
2009